Published in Ital Heart J on December 01, 2003
Refractory spasm of coronary arteries and grafted conduits after isolated coronary artery bypass surgery. Ann Thorac Surg (2011) 2.93
Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitation. J Thorac Cardiovasc Surg (2012) 2.68
Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database. Crit Care Med (2017) 2.67
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail (2011) 2.28
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail (2008) 2.11
Role of aliskiren on arterial stiffness and endothelial function in patients with primary hypertension. J Clin Hypertens (Greenwich) (2014) 2.02
Microvolt T-wave alternans for risk stratification in athletes with ventricular arrhythmias: correlation with programmed ventricular stimulation. Ann Noninvasive Electrocardiol (2008) 1.93
Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart (2010) 1.80
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation (2011) 1.71
Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J (2003) 1.67
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther (2008) 1.63
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol (2002) 1.49
High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion. Intern Emerg Med (2009) 1.44
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. J Cardiovasc Med (Hagerstown) (2006) 1.43
Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results. J Cardiovasc Med (Hagerstown) (2010) 1.42
Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse. Int J Cardiol (2005) 1.40
Out of the guidelines: should an intracardiac defibrillator be implanted in patients with recurrent early ventricular fibrillation due to recurrent acute myocardial infarction? J Cardiovasc Med (Hagerstown) (2007) 1.38
Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol (2011) 1.34
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. Eur J Heart Fail (2003) 1.25
The role of the kidney in heart failure. Eur Heart J (2012) 1.16
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16
Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol (2003) 1.13
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail (2007) 1.08
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail (2012) 1.06
The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail (2004) 1.05
Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation (2003) 1.05
Percutaneous coronary angioplasty in a patient with anomalous single coronary artery arising from the right sinus of Valsalva. Int J Cardiol (2006) 1.05
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Fail Rev (2014) 1.03
Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation (2010) 1.00
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail (2013) 1.00
Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score. Int J Cardiol (2011) 0.97
Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTIMIR). J Thorac Cardiovasc Surg (2012) 0.97
How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol (2009) 0.97
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther (2010) 0.95
Longitudinal strain predicts left ventricular mass regression after aortic valve replacement for severe aortic stenosis and preserved left ventricular function. Heart Vessels (2012) 0.94
Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail (2012) 0.92
Off-pump coronary artery bypass surgery technique for total arterial myocardial revascularization: a prospective randomized study. Ann Thorac Surg (2003) 0.91
Absence of inferior vena cava as a rare cause of deep venous thrombosis complicated by liver and lung embolism. Int J Cardiol (2003) 0.90
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. Scand J Clin Lab Invest (2008) 0.90
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev (2013) 0.90
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. Drugs (2010) 0.90
Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol (2010) 0.90
Is total arterial myocardial revascularization with composite grafts a safe and useful procedure in the elderly? Eur J Cardiothorac Surg (2003) 0.89
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail (2005) 0.89
Left internal thoracic artery-radial artery composite grafts as the technique of choice for myocardial revascularization in elderly patients: a prospective randomized evaluation. J Thorac Cardiovasc Surg (2004) 0.89
Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov (2009) 0.88
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. Eur J Cardiothorac Surg (2007) 0.88
How should we measure left atrium size and function? J Clin Ultrasound (2012) 0.87
Impact of preoperative anterior leaflet tethering on the recurrence of ischemic mitral regurgitation and the lack of left ventricular reverse remodeling after restrictive annuloplasty. J Am Soc Echocardiogr (2011) 0.87
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. Int J Cardiol (2010) 0.87
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail (2007) 0.86
[Idiopathic ventricular tachycardia: clinical characteristics and management]. G Ital Cardiol (Rome) (2010) 0.86
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) (2011) 0.86
Non-obstructive membranes of the left atrial appendage. Cardiovasc J Afr (2012) 0.85
Six-year prognosis of diabetic patients with coronary artery disease. Eur J Clin Invest (2011) 0.85
The pathophysiology of acute heart failure--it is a lot about fluid accumulation. Am Heart J (2007) 0.85
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Am J Cardiol (2012) 0.85
Pulmonary embolism complicated by impending paradoxical embolism - a case report and a review of literature. Kardiol Pol (2010) 0.84
Human fibrinogen/thrombin-coated collagen patch to control intraoperative severe pulmonary hemorrhage and air leakage after correction of a ruptured thoracic aortic aneurysm. Ann Thorac Surg (2011) 0.84
Long-term prognostic value of the right ventricular myocardial performance index compared to other indexes of right ventricular function in patients with moderate chronic heart failure. Echocardiography (2012) 0.84
Dynamic mild subaortic left ventricular obstruction caused by an accessory mitral valve attached to the anterior mitral valve in a young pregnant woman. Eur J Echocardiogr (2008) 0.84
Can we prevent or treat renal dysfunction in acute heart failure? Heart Fail Rev (2012) 0.83
Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation. J Am Soc Echocardiogr (2012) 0.83
Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail (2009) 0.83
Extraction of a coronary sinus lead: always so easy? J Cardiovasc Med (Hagerstown) (2017) 0.83
n-3 PUFAs and cardiovascular disease prevention. Future Cardiol (2010) 0.82
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. Clin Res Cardiol (2009) 0.82
Psoriasis and cardiovascular diseases. Acta Cardiol (2010) 0.82
A difficult diagnosis: right unilateral cardiogenic pulmonary edema. Usefulness of biochemical markers of heart failure for the correct diagnosis. Ital Heart J (2005) 0.82
Serum levels of different tumour markers in patients with chronic heart failure. Eur J Heart Fail (2005) 0.81
Effects of spironolactone on long-term mortality and morbidity in patients with heart failure and mild or no symptoms. Am J Med Sci (2014) 0.81